TNRC18-RNF216 Fusion FISH Probe
The TNRC18-RNF216 Fusion FISH Probe is used to confirm a fusion of the TNRC18 and RNF216 genes. The fusion of the TNRC18 and RNF216 genes has been associated with Lung Adenocarcinoma, Uterine Corpus Endometrial Carcinoma, Uterine Corpus Endometrial Carcinoma, Uterine Corpus Endometrial Carcinoma, and Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TNRC18-RNF216-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TNRC18-RNF216-20-AQAQ | 20 (40 μL) | 200 μL |
|
RNF216 Gene Summary
This gene encodes a cytoplasmic protein which specifically colocalizes and interacts with the serine/threonine protein kinase, receptor-interacting protein (RIP). Zinc finger domains of the encoded protein are required for its interaction with RIP and for inhibition of TNF- and IL1-induced NF-kappa B activation pathways. The encoded protein may also function as an E3 ubiquitin-protein ligase which accepts ubiquitin from E2 ubiquitin-conjugating enzymes and transfers it to substrates. Several alternatively spliced transcript variants have been described for this locus but the full-length natures of only some are known. [provided by RefSeq, Jul 2008]
Gene Name: Ring Finger Protein 216
Chromosome: CHR7: 5659671 -5821361
Locus: 7p22.1
TNRC18 Gene Summary
The Trinucleotide Repeat Containing 18 (TNRC18) gene is located on chr7 :5346422-5463177 at 7p22.1.
Gene Name: Trinucleotide Repeat Containing 18
Chromosome: CHR7: 5346422 -5463177
Locus: 7p22.1
Gene Diseases
The TNRC18 RNF216 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
| Uterine Corpus Endometrial Carcinoma |
| Uterine Corpus Endometrial Carcinoma |
| Uterine Corpus Endometrial Carcinoma |
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|